Sign in

Matthew Greenblatt

Research Analyst at Leerink Investment Partners

Matthew Greenblatt is a Research Analyst at Leerink Investment Partners, specializing in healthcare sector equity research. He has specifically covered companies such as ClearOne, participating in earnings calls and providing investment insights in this area. Greenblatt's public track record shows involvement in company coverage but does not detail quantitative performance metrics or industry rankings. His professional background also includes experience as an Analyst at Hawkeye Capital Management, SCS Financial, and Oppenheimer & Co., and he holds an undergraduate degree from Northeastern University College of Business.

Matthew Greenblatt's questions to CLEARONE (CLRO) leadership

Question · Q2 2017

Matthew Greenblatt from Leerink Investment Partners asked if ClearOne has considered strategic alternatives for the business and if it had been approached by any larger companies.

Answer

President, CEO and Chairman Zee Hakimoglu confirmed that the company continuously evaluates strategic alternatives but is currently focused on executing its long-term strategy to realize what it believes is undervalued potential. She declined to comment on any potential acquisition approaches, citing confidentiality.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts